Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ

(Reuters) - Ireland-based Jazz Pharmaceuticals Plc is nearing a deal to buy Celator Pharmaceuticals Inc for about $1.5 billion (1 billion pounds), the Wall Street Journal reported. The deal is likely to be announced on Tuesday, the Journal said citing people familiar with the matter. About three months ago, Celator said its Vyxeos treatment helped older high-risk patients with a deadly form of leukemia live longer than those who received the standard of care regimen in a late stage clinical tria